IRLAB Therapeutics
GOTHENBURG, SE / ACCESSWIRE / November 5, 2021 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)
IRLAB (Nasdaq Stockholm:IRLAB A); Members of the nomination committee ahead of annual general meeting 2022 have been appointed.
According to the instruction for appointment of the nomination committee in IRLAB Therapeutics AB, resolved at the annual general meeting on May 6, 2021, the nomination committee shall, besides the chairman of the board, consist of representatives of the three largest shareholders, or groups of shareholders, registered by Euroclear Sweden AB as per August 31, 2021.
As the three largest shareholders or groups of shareholders now have appointed their representatives, the nomination committee has held its first meeting.
The nomination committee ahead of the AGM 2022 consists of the following members:
- Daniel Johnsson , chairman of the nomination committee , entrepreneur, business developer and investor, appointed by a group of shareholders representing about 21 percent of shares and votes;
- Bo Rydlinger , background from banking and investments, appointed by a group of shareholders representing about 15 percent of shares and votes;
- Clas Sonesson , Chief Scientific Officer (CSO) at IRLAB and one of IRLAB's founders. Appointed by a group of shareholders that consists of the company's founders representing about 10 percent of shares and votes; and
- Gunnar Olsson , chairman of the board of IRLAB Therapeutics AB.
The members of the nomination committee has been appointed by owners who represent a total of about 46 per cent of the total number of shares and votes in IRLAB Therapeutics AB as per Augst 31, 2022.
Information about the nomination committee's work and the instruction to the nomination committee can be found on the company website under the section for Corporate Governance. The nomination committee's proposal will be presented in the summon to the annual general meeting 2022 and on the company's web page: www.irlab.se.
Shareholders who wish to submit proposals to the nomination committee shall do this in writing, no later than January 15, 2022, per e-mail info@irlab.se or per mail to the company's postal address.
For more information
Daniel Johnsson, Chair of the nomination committee
Phone: +46 73 687 64 00
E-mail: daniel.captech@gmail.com
Gunnar Olsson, Chair of the board
Phone: +46 70 576 14 02
E-mail: gunnar.olsson@irlab.se
About IRLAB
IRLAB is a Swedish research and development company that focuses on developing novel treatments in Parkinson's disease. The company's most advanced candidates, mesdopetam (IRL790) and pirepemat (IRL752), have completed Phase IIa studies and are designed to treat some of the most difficult symptoms related to Parkinson's disease: involuntary movements (PD-LIDs), psychosis (PDP) and symptoms linked to cognitive decline such as impaired balance and increased risk of falls (PD-Falls). Through the proprietary research platform, ISP (the Integrative Screening Process), IRLAB discovers and develops unique drug candidates for central nervous system (CNS)-related disorders where large and growing medical needs exist. In addition to the clinical candidates, the ISP platform has also generated several CNS programs that are now in preclinical phase. The project portfolio comprises a combination of the fully-funded mesdopetam program, run in collaboration with global partner Ipsen, as well as innovative in-house programs from preclinical to Phase IIb. IRLAB is listed on Nasdaq Stockholm Main Market. More information on www.irlab.se.
SOURCE: IRLAB Therapeutics
View source version on accesswire.com:
https://www.accesswire.com/671354/Nomination-Committee-in-IRLAB-Appointed-Ahead-of-Annual-General-Meeting-2022
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
DCLI Drives Fleet Efficiencies with BlackBerry Radar Deployment Across 100,000 Chassis22.5.2025 07:56:00 CEST | Press release
Innovative Asset Monitoring Technology Selected by U.S.'s Largest Container Chassis Provider WATERLOO, ON / ACCESS Newswire / May 22, 2025 / BlackBerry Limited (NYSE:BB)(TSX:BB) today announced that Direct ChassisLink, Inc. ("DCLI"), the largest provider of container chassis to the U.S. intermodal industry, will deploy BlackBerry® Radar® across 100,000 of its DCL53 domestic 53-foot chassis. The rollout is part of a major initiative DCLI is undertaking to enhance the quality, reliability, visibility and operational efficiency of its fleet, with a view to setting a new freight industry standard for data driven decision-making. The deployment represents a deepening in the companies' technological collaboration. DCLI has utilized Radar devices on a subset of its fleet for over five years and after seeing the reliability and intelligence they provide, decided to exponentially increase the number of its chassis deployed with the solution while also recognizing Radar as a top tier supplier. W
Sauce Labs Becomes FSQS-Certified, Cementing Role as QA Leader for EMEA Finance22.5.2025 03:25:00 CEST | Press release
Accreditation reinforces Sauce Labs' position as the trusted software quality partner for Europe's most regulated financial institutions. SAN FRANCISCO, CA / ACCESS Newswire / May 22, 2025 / Sauce Labs, the leading platform for continuous quality, today announced it has achieved Financial Services Qualification System (FSQS) certification. This milestone further fuels the company's accelerating momentum as more financial services organizations across EMEA seek to modernize their digital infrastructure while meeting rigorous compliance requirements. With European institutions projected to spend over $1 trillion on digital transformation this year-and regulatory scrutiny at its highest level since GDPR-the need for trusted, compliant technology partners has never been greater. Sauce Labs' FSQS certification comes at a pivotal moment, reinforcing its role as the go-to quality assurance platform for modern financial services teams across EMEA. The FSQS certification, administered by Hellio
Pet Diets Are Quietly Contributing to Climate Change - but There's a Simple Fix21.5.2025 14:00:00 CEST | Press release
LONDON, UNITED KINGDOM / ACCESS Newswire / May 21, 2025 / Feeding your dog or cat might be doing more damage to the planet than you think. A new study has revealed that conventional meat-based pet food carries a largely unrecognized environmental cost - contributing significantly to land use, greenhouse gas (GHG) emissions, and climate breakdown. The review, just published, found that pet food production is closely tied to the livestock industry, which is responsible for at least one-fifth of annual global GHG emissions. With the world's pet population now approaching one billion animals, the impacts are no longer minor. In the United States alone, dog and cat diets account for 25-30% of the environmental toll of livestock farming. One analysis even found that a single medium-sized dog's diet in Japan had a greater environmental footprint than the average Japanese person's diet. But experts say there's a powerful - and practical - solution. Stated Billy Nicholles, the lead author, "Swi
Innodata to Participate in Multiple Upcoming Investor Conferences15.5.2025 16:15:00 CEST | Press release
NEW YORK, NY / ACCESS Newswire / May 15, 2025 / INNODATA INC. (Nasdaq:INOD), a leading data engineering company, today announced that it will participate in several upcoming investor conferences in May and June 2025. The scheduled conferences include: 22nd Annual Craig-Hallum Institutional Investor Conference May 28, 2025, Minneapolis TD Cowen 53rd Annual Technology, Media & Telecom Conference May 29, 2025, New York Stifel's Eighth Annual Boston Cross Sector Insight Conference June 4, 2025, Boston Maxim Group 2025 Virtual Tech Conference June 5, 2025, Virtual Mizuho Technology Conference 2025 June 10, 2025, New York Jack Abuhoff, CEO, and Aneesh Pendharkar, SVP of Finance and Corporate Development, will be available for one-on-one meetings with investors at each conference. Investors who wish to request a meeting with Innodata at any of these conferences should contact their representative at the sponsoring investment firm. Additionally, Jack Abuhoff will be presenting at the TD Cowen
Loar Announces Pricing of Secondary Public Offering14.5.2025 21:55:00 CEST | Press release
WHITE PLAINS, NY / ACCESS Newswire / May 14, 2025 / Loar Holdings Inc. (NYSE:LOAR) ("Loar") announced today the pricing of a secondary underwritten public offering of 9,000,000 shares of its common stock by certain of its stockholders at $83.41 per share. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 1,350,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on May 16, 2025, subject to customary closing conditions. The selling stockholders will receive all of the proceeds from this offering. Loar is not selling any shares of common stock in this offering and will not receive any proceeds from this offering. Jefferies and Morgan Stanley are acting as lead book runners for the offering. Moelis & Company, Citigroup and RBC Capital Markets are additionally acting as book runners. Blackstone is acting as co-manager. An automatic shelf regis
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom